Life Technologies Signs Licensing Agreement with Suzhou Ribo Life SciencesAgreement formed for the development of potent siRNA therapeutics in China.
Experimental Vaccine Shows Promise against TB MeningitisStudy in animals lays groundwork for new prevention strategies in brain TB.
New Way to Improve Antibiotic ProductionA discovery has been made which could make it easier to scale up antibiotic production for commercialisation.
Researchers Pioneer Treatment for Viral Infection Common in ChildrenProfessor Peter Openshaw and team develops a new technique used in tackling a wide range of other diseases.
Racial and Economic Gap in Awareness of Lifesaving HPV VaccineResearch finds worrisome racial, economic, educational, and gender gaps in awareness about the lifesaving vaccine for HPV.
Retrogenix Points to New Drug Target for Malaria in ChildrenThe discovery reported this week in Nature.
Results of the ROTAVAC Rotavirus Vaccine Study in IndiaStatement of Anthony S. Fauci, M.D. Director, National Institute of Allergy and Infectious Diseases National Institutes of Health.
BBSRC is Major Partner in Europe-wide Synthetic Biology FundingBBSRC is contributing €3M as a major partner in a new call for research projects in Synthetic Biology.
Cobra Biologics and Vaccibody Sign Agreement to Manufacture DNA VaccineCompanies announce agreement to manufacture Vaccibody’s lead DNA vaccine candidate against HPV-induced malignancies.
Cocaine Vaccine Passes Key Testing HurdleNew anti-cocaine vaccine research shows drug can't reach the brain, human clinical trials on the horizon.
